Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond (Q35596686)
Jump to navigation
Jump to search
scientific article published on 23 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond |
scientific article published on 23 November 2011 |
Statements
1 reference
9 references
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond (English)
1 reference
8 references
23 November 2011
10 references
3 April 2019
31 July 2019
17 September 2019
28 September 2019
2 October 2019
15 December 2019
14 September 2020
8 December 2020
17 July 2021
10 references
3 April 2019
31 July 2019
17 September 2019
28 September 2019
2 October 2019
15 December 2019
14 September 2020
8 December 2020
17 July 2021
1 November 2011
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference